NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE106211 Query DataSets for GSE106211
Status Public on May 17, 2018
Title ChIP-seq targeting Myc-tagged UL34 from human fibroblasts infected with human cytomegalovirus at 48 hours post infection
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Purpose: To identify interactions of the viral DNA-binding protein, UL34, with the viral genome during lytic-phase replication.
Methods: Human fibroblasts were infected with human cytomegalovirus expressing Myc-tagged UL34 in biological duplicate. At 48 hours post infection, ChIP was performed with anti-Myc tag antibody (Cell Signaling) and the resulting DNA fragments were sequenced on Illumina MiSeq. Reads were trimmed and duplicates removed. Reads passing quality filter were aligned to a custom reference genome containing both the human genome with the human cytomegalovirus genome as an additional chromosome to prevent read assignment bias with CLC Genomics Workbench verison 9.0. Enrichment of UL34 in the viral origin of lytic replication (oriLyt) was calculated by dividing read counts from the ChIP'd samples (Myc-UL34-1, Myc-UL34-2) by those from non-ChIP whole cell lysate (Input) with a 125bp sliding window (25bp overhang) after adjusting for total read count variances. An additional sample containing DNA that was subjected to the ChIP protocol in the absence of antibody (No Antibody) was compared to the Input to determine background enrichment.
Results: Several peaks were identified when comparing the Myc-UL34-ChIP samples to Input. UL34 is bound to the viral oriLyt at 48 hours post infection near the three previously defined UL34-binding sites to varying degrees, as well as additional locations within the region. No peaks were identified when comparing the No Antibody and Input samples.
 
Overall design Occupancy of HCMV UL34 in the viral oriLyt.
 
Contributor(s) Slayton M, Biegalke BJ
Citation(s) 29626748
Submission date Oct 26, 2017
Last update date May 15, 2019
Contact name Mark Daniel Slayton
E-mail(s) ms915613@ohio.edu
Phone 313-204-7776
Organization name Ohio University
Department Biomedical Sciences
Lab Life Sciences Building 230
Street address 7 Depot Street
City Athens
State/province Ohio
ZIP/Postal code 45701
Country USA
 
Platforms (1)
GPL15520 Illumina MiSeq (Homo sapiens)
Samples (4)
GSM2831614 Myc-UL34_ChIPseq-1
GSM2831615 Myc-UL34_ChIPseq-2
GSM2831616 No_Antibody_ChIPseq
Relations
BioProject PRJNA415928
SRA SRP121635

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE106211_RAW.tar 10.0 Kb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap